A list of top wide moat stocks includes Pfizer Inc. (NYSE:PFE), with its diverse drug portfolio and cost-cutting initiatives. Analysts see potential in Pfizer, but also recommend exploring undervalued AI stocks for higher returns in a shorter timeframe.